Keyphrases
Active Ulcerative Colitis
16%
Adalimumab
10%
Anti-tumor Necrosis Factor (anti-TNF)
11%
Bmal1
10%
Body Mass Index
25%
C-reactive Protein
9%
Celiac Disease
48%
Celiac Disease Autoimmunity
16%
Circadian Clock
10%
Clinical Outcomes
9%
Clock Gene Expression
12%
Clock Genes
26%
Confidence Interval
15%
Crohn's Disease
26%
CRY1
12%
Disease Activity
12%
Disease Course
12%
Disease Exacerbation
9%
Fecal Calprotectin
14%
Gene Disruption
17%
Gluten-free Diet
17%
Healthy Controls
10%
High Risk
10%
Histological Index
14%
Ileocolonoscopy
10%
Inflammation
11%
Inflammatory Bowel Disease
78%
Inflammatory Markers
14%
Infliximab
18%
Israel
11%
Maintenance Phase
10%
Newly Diagnosed
31%
Non-associated
12%
Obstructive Sleep Apnea
9%
Odds Ratio
9%
Pediatric
20%
Pediatric Inflammatory Bowel Disease
20%
Pediatric Patients
33%
Pediatric Ulcerative Colitis
20%
Per1
10%
Per2
12%
Remission
10%
Severe Disease
12%
Temporal Trends
10%
Tissue Transglutaminase Antibodies
10%
Ulcerative Colitis
36%
Ulcerative Colitis Patient
13%
Upper Quartile
10%
White Blood Cells
9%
Working Diagnosis
32%
Medicine and Dentistry
Abdominal Pain
8%
Acute Pancreatitis
8%
Allogeneic Hematopoietic Stem Cell Transplantation
8%
Autoimmunity
8%
Blepharitis
8%
Body Mass Index
21%
C Reactive Protein
8%
Circadian Rhythm
9%
Coeliac Disease
49%
Crohn's Disease
18%
Curcumin
8%
Disease Activity
13%
Disease Course
10%
Disease Exacerbation
9%
Diseases
14%
Elevated Transaminases
8%
Endomysium antibody
8%
Endoscopy
11%
Faecal Calprotectin
9%
Family History
8%
Gastrointestinal Endoscopy
17%
Gene Disruption
16%
Gene Targeting
16%
Gluten Free Diet
9%
Histopathology
8%
Immunoglobulin A Antibody
8%
Inflammatory Bowel Disease
53%
Infliximab
11%
Juvenile Idiopathic Arthritis
8%
Leukocyte
12%
Metabolic Syndrome
8%
Nitrous Oxide
8%
Observational Study
8%
Obstructive Sleep Apnea
8%
Patient with Crohn's Disease
14%
Patient with Inflammatory Bowel Disease
21%
Patient with Ulcerative Colitis
9%
Pediatrics
100%
Pediatrics Patient
18%
Prevalence
16%
Protein Glutamine Gamma Glutamyltransferase
11%
Psychogenic Pain
8%
Retinol
8%
Retinol Deficiency
8%
Retrospective Study
15%
Therapeutic Drug Monitoring
8%
Tissue Sampling
8%
Tumor Necrosis Factor
23%
Ulcerative Colitis
32%
Ustekinumab
8%
